Markets
NBY

Health Care Sector Update for 08/12/2016: SSKN,CHRX,NBY

A generic image of money and a calculator
Credit: Shutterstock photo

Top Health Care Stocks

JNJ -0.53%

PFE -0.67%

MRK -0.11%

ABT -0.60%

AMGN +0.25%

Health care stocks continue their retreat this afternoon, with the NYSE Health Care Index set to finish with a 0.4% decline while shares of health care companies in the S&P 500 also were down about 0.3% as a group.

In company news, STRATA Skin Sciences Inc. ( SSKN ) slumped Friday, after the dermatology company reported a nearly 12-fold jump in revenue during the April-to-June period compared with the same quarter last year but still missing the lone analyst estimate for the quarter.

Revenue grew to $7.7 million during the three months ended June 30, rising from $600,000 in revenue during the year-ago period but missing the single-analyst call looking for $9.13 million in quarterly revenue. The company also earned $498,000, or $0.23 per share, reversing a $7.85 million net loss and beating the lone analyst call looking for a $0.10 per share net loss.

SSKN shares were down almost 10% in late trade at 65 cents apiece, previously sliding to a session low of 61 cents a share.

In other sector news,

(+) NBY, Narrows Q2 net loss to $0.36 per share from $1.84 per share loss last year, exceeding the single-analyst estimate expecting a $0.59 per share loss. Revenue almost doubles, rising 190% from year-ago levels to $2.7 mln, also beating the $1.8 mln analyst call.

(-) CXRX, Reports adjusted Q2 net income of $1.38 per share, missing the Capital IQ consensus by $0.02 per share. Revenue climbs 208% to $231.7 million, matching the $232.57 million analyst mean. Suspends quarterly dividend.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NBY SSKN

Other Topics

US Markets